March 20th, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Sponsored Research
December 21st, 2016
Platform for rapid innovation
New agreement streamlines Harvard research collaborations with Facebook
March 21st, 2016
Blavatnik Biomedical Accelerator at Harvard University announces license and collaboration agreement
Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.
December 23rd, 2015
Targeting fat-tissue hormone may lead to type 2 diabetes treatment
UCB-funded Harvard study describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
July 21st, 2015
Facebook for the proteome
Biologists at Harvard Medical School, with support from Biogen, have mapped protein networks in the human 'interactome'.
